Israeli tech had a busy identity-and-security week. The funding headline was Dream’s $260 million Series C at a $3 billion valuation, a round that sits directly at the
Israeli tech had one of those weeks that captures the market’s current contradiction. On one side, capital is still flowing into high-conviction categories like defense-tech, AI commerce, biotech
Happy Shavuot! Israeli venture had a very telling week. Decart’s $300M round showed that global investors are still willing to write massive checks for technically differentiated AI infrastructure
The Q1 2026 tech review report was published this week, and Israeli startups raised $3.4 billion (despite much of that quarter being characterised by war), signalling a return
This week’s signal: more capital is still flowing into Israeli startups, but conviction is concentrating around fewer themes. Cyber, AI infrastructure, and capital-efficient enterprise software continue to stand
Press ↩ to search · Esc to close · ⌘K to open anywhere
Cookies on IsraelVC
We use essential cookies to keep the site working. We’d also like to use analytics cookies to understand how founders and fund managers use IsraelVC so we can improve it. Analytics only loads if you agree.